Dr. M. Vijayakumar is the Consultant and Professor in the Department of Adult Cardiology, Amrita Hospital, Kochi.
- Adult Interventional Cardiology
- Endovascular Aortic Aneurysm Repair including Hybrid Aortic Stenting
- Coronary intervention
MBBS
MD (General Medicine)
DM (Cardiology)
DNB (Medicine)
Fellowship - Cardiology
Thoraxcenter, Rotterdam
- English
- Malayalam
- Co Investigator for MICHEL ANGELO OASIS 6 (STEMI)
- Co Investigator for Peri Operative Ischemic Evaluation study (POISE STUDY). Co investigator OLYMPIA REGISTRY
- GlObal TAXUS Liberté RegistrY PrograM to SupPort Worldwide CommerciAlization – Inter-Continental Launch Phase
- Co Investigator for RELY study Randomized evaluation of long term anticoagulant therapy (RE-LY) comparing the efficacy and safety of two blinded doses of dabigatran etexilate with open label warfarin for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: prospective, multi-centre, parallel-group, non-inferiority trial
- Co Investigator for FUSION II
- Co Investigaor – Cardiovascular disease surveillance among the adivasi population of Wayanad district; ICMR
- Co investigator – SEPIA TIMI42
- Investigator – Balance Study
- Investigator – Randomized study of coconut oil and sunflower oil in coronary artery disease patents won standard medical treatment
- Investigator – Astronaut study.
Dr. M. Vijayakumar is the Consultant and Professor in the Department of Adult Cardiology, Amrita Hospital, Kochi.
- Adult Interventional Cardiology
- Endovascular Aortic Aneurysm Repair including Hybrid Aortic Stenting
- Coronary intervention
MBBS
MD (General Medicine)
DM (Cardiology)
DNB (Medicine)
Fellowship - Cardiology
Thoraxcenter, Rotterdam
- English
- Malayalam
- Co Investigator for MICHEL ANGELO OASIS 6 (STEMI)
- Co Investigator for Peri Operative Ischemic Evaluation study (POISE STUDY). Co investigator OLYMPIA REGISTRY
- GlObal TAXUS Liberté RegistrY PrograM to SupPort Worldwide CommerciAlization – Inter-Continental Launch Phase
- Co Investigator for RELY study Randomized evaluation of long term anticoagulant therapy (RE-LY) comparing the efficacy and safety of two blinded doses of dabigatran etexilate with open label warfarin for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: prospective, multi-centre, parallel-group, non-inferiority trial
- Co Investigator for FUSION II
- Co Investigaor – Cardiovascular disease surveillance among the adivasi population of Wayanad district; ICMR
- Co investigator – SEPIA TIMI42
- Investigator – Balance Study
- Investigator – Randomized study of coconut oil and sunflower oil in coronary artery disease patents won standard medical treatment
- Investigator – Astronaut study.